TITLE

Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry

AUTHOR(S)
Chesnaye, Nicholas C.; Schaefer, Franz; Groothoff, Jaap W.; Caskey, Fergus J.; Heaf, James G.; Kushnirenko, Stella; Lewis, Malcolm; Mauel, Reiner; Maurer, Elisabeth; Merenmies, Jussi; Shtiza, Diamant; Topaloglu, Rezan; Zaicova, Natalia; Zampetoglou, Argyroula; Jager, Kitty J.; van Stralen, Karlijn J.
PUB. DATE
August 2015
SOURCE
Nephrology Dialysis Transplantation;Aug2015, Vol. 30 Issue 8, p1377
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Considerable disparities exist in the provision of paediatric renal replacement therapy (RRT) across Europe. This study aims to determine whether these disparities arise from geographical differences in the occurrence of renal disease, or whether country-level access-to-care factors may be responsible. Methods. Incidence was defined as the number of new patients aged 0-14 years starting RRT per year, between 2007 and 2011, per million children (pmc), and was extracted from the ESPN/ERA-EDTA registry database for 35 European countries. Country- level indicators onmacroeconomics, perinatal care and physical access to treatment were collected through an online survey and from the World Bank database. The estimated effect is presented per 1SD increase for each indicator. Results. The incidence of paediatric RRT in Europewas 5.4 cases pmc. Incidence decreased from Western to Eastern Europe (-1.91 pmc/1321 km, P < 0.0001), and increased from Southern to Northern Europe (0.93 pmc/838 km, P = 0.002). Regional differences in the occurrence of specific renal diseases were marginal. Higher RRT treatment rates were found in wealthier countries (2.47 pmc/€10 378 GDP per capita, P < 0.0001), among those that tend to spend more on healthcare (1.45 pmc/1.7% public health expenditure, P < 0.0001), and among countries where patients pay less out-of-pocket for healthcare (-1.29 pmc/11.7% out-of-pocket health expenditure, P < 0.0001). Country neonatalmortality was inversely related with incidence in the youngest patients (ages 0-4, -1.1 pmc/2.1 deaths per 1000 births, P = 0.10). Countries with a higher incidence had a lower average age at RRT start, which was fully explained by country GDP per capita. Conclusions. Inequalities exist in the provision of paediatric RRT throughout Europe, most of which are explained by differences in country macroeconomics, which limit the provision of treatment particularly in the youngest patients. This poses a challenge for healthcare policy makers in their aim to ensure universal and equal access to high-quality healthcare services across Europe.
ACCESSION #
109519822

 

Related Articles

  • Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium. Tromp, Wilma F.; van der Lee, Johanna H.; Offringa, Martin; Bouts, Antonia H. M.; Collard, Laure; Cransberg, Karlien; van Damme-Lombaerts, Rita; Godefroid, Nathalie; van Hoeck, Koen; Koster-Kamphuis, Linda; Lilien, Marc R.; Raes, Ann; Groothoff, Jaap W. // Archives of Disease in Childhood;Dec2011, Vol. 96 Issue 12, p1093 

    The article describes a collaborative quality improvement approach in caring for children with end-stage renal disease (ESRD) in the Netherlands and Belgium. It focuses on the development of the RICH-Q Project which aims to improve the quality of care (QoC) for children with ESRD. It provides an...

  • Reversible diabetes mellitus during growth hormone therapy in chronic renal failure. Filler, Guido; Franke, Doris; Amendt, Peter; Ehrich, Jochen H. H. // Pediatric Nephrology;1998, Vol. 12 Issue 5, p405 

    A 12-year-old girl with short stature due to idiopathic Fanconi syndrome and chronic renal failure was treated with recombinant human growth hormone (rhGH). There was no family history of diabetes mellitus and the glucose tolerance before treatment was normal. Intravenous glucose tolerance tests...

  • Management of Pediatric Patients With Chronic Kidney Disease. Miller, Deborah; MacDonald, Dina // Nephrology Nursing Journal;Jul/Aug2006, Vol. 33 Issue 4, p415 

    Chronic kidney disease in children is associated with complications that require nursing interventions in both the inpatient and outpatient settings. Given the progressive nature of the disease and the complexity of the treatment regimen, it is important that nurses be comfortable implementing...

  • Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program. Bouissou Soares, Cristina M.; Diniz, José Silvério S.; Lima, Eleonora M.; Penido Silva, Jose M.; Oliveira, Gilce R.; Canhestro, Monica R.; Colosimo, Enrico A.; Simoes e Silva, Ana Cristina; Oliveira, Eduardo A. // Pediatric Nephrology;Nov2008, Vol. 23 Issue 11, p2039 

    The purpose of this retrospective cohort study was to describe the outcome of 107 patients with chronic kidney disease (CKD) admitted to a pre-dialysis interdisciplinary management program from 1990 to 2006. The events of interest were progression to CKD stage 5 (renal survival), patient...

  • Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Fine, Richard // Pediatric Nephrology;Apr2010, Vol. 25 Issue 4, p725 

    Dramatic changes have occurred in our understanding of the etiology of the growth retardation associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD) during the past 50 years. Significant interest has been focused on preventing and/or correcting the growth retardation...

  • Children of non-Western origin with end-stage renal disease in the Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with Western children. Schoenmaker, Nikki J.; Haverman, Lotte; Tromp, Wilma F.; van der Lee, Johanna H.; Offringa, Martin; Adams, Brigitte; Bouts, Antonia H. M.; Collard, Laure; Cransberg, Karlien; van Dyck, Maria; Godefroid, Nathalie; van Hoeck, Koenraad; Koster-Kamphuis, Linda; Lilien, Marc R.; Raes, Ann; Taylan, Christina; Grootenhuis, Martha A.; Groothoff, Jaap W. // Nephrology Dialysis Transplantation;Feb2014, Vol. 29 Issue 2, p448 

    Background Many children with end-stage renal disease (ESRD) living in Western Europe are of non-Western European origin. They have unfavourable somatic outcomes compared with ESRD children of Western origin. In this study, we compared the Health-related Quality of Life (HRQoL) of both groups....

  • Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium—report from the RICH-Q study. Tromp, Wilma F.; Schoenmaker, Nikki J.; van der Lee, Johanna H.; Adams, Brigitte; Bouts, Antonia H. M.; Collard, Laure; Cransberg, Karlien; Van Damme-Lombaerts, Rita; Godefroid, Nathalie; van Hoeck, Koenraad; Koster-Kamphuis, Linda; Lilien, Marc R.; Raes, Ann; Offringa, Martin; Groothoff, Jaap W. // Nephrology Dialysis Transplantation;May2012, Vol. 27 Issue 5, p1984 

    Background. The low prevalence of childhood end-stage renal disease and the small centre sizes have been a barrier for clinical studies and the development of evidence-based guidelines for chronic renal replacement therapy (cRRT) in children. Few data exist on the quality of care for these...

  • Chronic renal failure in Sudanese children: aetiology and outcomes. Ali, El-Tigani; Abdelraheem, Mohamed; Mohamed, Reem; Hassan, Einas; Watson, Alan // Pediatric Nephrology;Feb2009, Vol. 24 Issue 2, p349 

    The provision of tertiary paediatric nephrology facilities has led to increasing referrals of children with chronic renal failure (CRF). We report the aetiology and outcomes over 5 years, during which period the improving socio-economic situation has allowed increasing provision of dialysis and...

  • Growth over 10 years following a 1-year trial of growth hormone therapy. Rees, L.; Ward, G.; Rigden, S. P. A. // Pediatric Nephrology;Mar2000, Vol. 14 Issue 4, p309 

    The growth of short children with chronic renal failure (CRF) and renal transplants was assessed over 10 years following entry into a 1-year trial of recombinant human growth hormone (rhGH) therapy. Patients were divided into three groups: 6 prepubertal patients with CRF (group 1), mean (range)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics